Guillermo Tearney

ROX Medical, Inc. manufactures medical ultrasonic scanning devices. It offers ROX Coupler that is intended for use in patients with treatment resistant hypertension to lower blood pressure by reducing peripheral vascular resistance and improving vascular compliance; and in patients with chronic obstructive pulmonary disease to improve breathing, reduce symptoms of chronic bronchitis, and improve exercise tolerance. The company was founded by Rodney Brenneman and John Faul in 2004 and is headquartered in San Clemente, CA.

Medtronic Ablation Frontiers LLC provides technology solutions for cardiac therapy to cure heart arrhythmias focusing on a trial fibrillation. The firm focuses in the treatment of ablation therapy. The company was founded in 2004 and is headquartered in Carlsbad, CA.

Infraredx, Inc. is a developed cardiovascular imaging devices. Its product were TVC Imaging System dual-modality intravascular imaging system with the ability to assess vessel structure and plaque composition via integrated NIRS near infrared spectroscopy lipid-core plaque LCP detection and enhanced IVUS imaging technology. The company was founded by James E. Muller in 1999 and is headquartered in Bedford, MA.

Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC.

Cavion, Inc. engages in development of pharmaceuticals products. It produces oncology drugs to treat solid tumors that selectively inhibits the t-type calcium channel. The company was founded by Andrew J. Krouse, Lloyd S. Gray, and Timothy L. Macdonald in 2005 and is headquartered in Charlottesville, VA.

Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA.

Advanced Animal Diagnostics, Inc. develops integrated systems and solutions for the detection of animal diseases. The firm engages in the researching, developing and commercializing on-farm diagnostic tests, such as QScout MLD for early detection of subclinical mastitis in dairy cows. It also provides solutions for the diagnosis and treatment of veterinary health problems including mastitis and other animal diseases. The company was founded by Rodolfo Rodriguez and Victor M. Minton in July 2001 and is headquartered in Durham, NC.

Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA.

NinePoint Medical, Inc. develops and manufactures medical devices. It designs, manufactures, and sells an Optical Coherence Tomography (OCT) imaging platform for clinical use in gastroenterology, pulmonology, urology, gynecology, evaluation of human tissue microstructure. The company is headquartered in Bedford, MA.

Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC.

Sensitech, Inc. provides cold chain solutions for monitoring temperature-sensitive and perishable products. Its products encompasses in software, dataloggers, logistics security, chemical and electronic indicator, strip chart recorders, ethylene absorption, facility monitoring, and accessories. The company was founded by Ernest M. Santin in 1990 and is headquartered in Beverly, MA.

Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts.

Part of CONMED Corp., Medtronic Andover Medical, Inc. is an American company that manufactures disposable electrodes. Medtronic Andover Medical was acquired by CONMED Corp. from Medtronic, Inc. on July 13, 1993.

Part of Abbott Laboratories, Abbott Vascular Devices develops and manufactures cardiovascular devices for people with cardiovascular disease. The company is based in Redwood City, CA.

Mid-Atlantic Venture Funds (Mid-Atlantic Venture Funds) is a venture capital firm founded in 1984 by Fred J. Beste. The firm is headquartered in Bethlehem, Pennsylvania.

Visiogen, Inc. develops products for cataract and refractive patients. It offers synchrony dual-optic accommodating intraocular lens and pre-loaded injector, which provide distance, intermediate, and near vision to presbyopic cataract patients. The company was founded on March 19, 2001 and is headquartered in Abbott Park, IL.

The Cardiovascular Research Foundation operates as a civic and social association. The non-profit company is based in New York, NY. The company was founded by Charles A. Simonton.

Thoratec LLC provides semiconductor and medical products. Its products include medical blood pumps, mixers, and flow control systems. The firm provides its services to the semiconductor industry. The company was founded in 2001 and is headquartered in Waltham, MA.

Michigan Ross Zell Lurie Institute / Venture Capital/ (Zell Lurie Institute) is a venture capital subsidiary of Zell Lurie Institute for Entrepreneurial Studies Studies founded in 1997 by Samuel Zell, Ann Lurie and Robert H. Lurie. The firm is headquartered in Ann Arbor, Michigan.

Portaero, Inc. develops and manufactures medical devices. The company was founded on May 11, 2007 and is headquartered in Menlo Park, CA.

Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd

OKM Capital Management LLC (OKM Capital) is a venture capital firm founded in 2013 by Donna Cordner, Katerina Fialkovskaya, Mindaugas Leika and Oleg Shchapov. The firm is headquartered in Boston, Massachusetts.

Nido Surgical, Inc. develops and manufactures medical devices. It offers CardioPort, a platform designed to enable video-endoscopic trans-cardiac surgical repairs inside the beating heart and trans-thoracic electrophysiology (EP) procedures. The company was founded by Pedro del Nido and Nikolay Vasilyev and is headquartered in Lexington, MA.

Gregor Diagnostics, Inc. develops and manufactures molecular diagnostics screening tests for prostate cancer. It provides proprietary system to maintain biomarker stability in the seminal fluid. The company was founded by Tobias Zutz in February 2016 and is headquartered in Madison, WI.

International Physicians for the Prevention of Nuclear War is an organization that advocates for the elimination of all nuclear weapons. The non-profit company is based in Somerville, MA. The organization believes that this is an urgent medical, humanitarian, and public health imperative. The company was founded by James E. Muller.

Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC.